TMCnet News

NEXTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating NexTech AR Solutions Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm
[February 13, 2020]

NEXTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating NexTech AR Solutions Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm


Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against NexTech AR Solutions Corp. (Other OTC: NEXCF) on behalf of NexTech stockholders. Our investigation concerns whether NexTech has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On February 10, 2020, Hindenburg Research published a report alleging that NexTech "engaged in a paid promotion spree, pumping its stock through at least 8 promotion outlets" and that many of its customers "were either entirely unaware that they had a relationship with the company or had never actually implemented the product."

On this news, the Company's share price ell $0.36, or nearly 22%, to close at $1.29 per share on February 10, 2020.



If you purchased or otherwise acquired NexTech shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato or Marion Passmore by email at [email protected], or telephone at (646) 860-9156, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:


Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.


[ Back To TMCnet.com's Homepage ]